iifl-logo-icon 1

Gujarat Terce Laboratories Ltd Share Price

77.38
(1.88%)
Dec 4, 2024|03:47:00 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open77.39
  • Day's High77.39
  • 52 Wk High94.9
  • Prev. Close75.95
  • Day's Low74.61
  • 52 Wk Low 25.84
  • Turnover (lac)1.5
  • P/E21.52
  • Face Value10
  • Book Value11.94
  • EPS3.53
  • Mkt. Cap (Cr.)57.42
  • Div. Yield0
View All Historical Data
No Records Found

Gujarat Terce Laboratories Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

77.39

Prev. Close

75.95

Turnover(Lac.)

1.5

Day's High

77.39

Day's Low

74.61

52 Week's High

94.9

52 Week's Low

25.84

Book Value

11.94

Face Value

10

Mkt Cap (₹ Cr.)

57.42

P/E

21.52

EPS

3.53

Divi. Yield

0

Gujarat Terce Laboratories Ltd Corporate Action

7 Jun 2023

12:00 AM

BookCloser

arrow

29 Mar 2024

12:00 AM

EGM

arrow

9 Aug 2024

12:00 AM

AGM

Announcement Date: 09 Aug, 2024

arrow

18 Oct 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Gujarat Terce Laboratories Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Gujarat Terce Laboratories Ltd SHAREHOLDING SNAPSHOT

04 Dec, 2024|06:28 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 37.02%

Foreign: 0.00%

Indian: 37.02%

Non-Promoter- 62.97%

Institutions: 0.00%

Non-Institutions: 62.97%

Custodian: 0.00%

Share Price

Gujarat Terce Laboratories Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

7.42

7.42

7.42

7.42

Preference Capital

0

0

0

0

Reserves

-0.31

-0.56

1.11

0.24

Net Worth

7.11

6.86

8.53

7.66

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

40.13

25.17

37.54

29.01

yoy growth (%)

59.4

-32.93

29.39

14.73

Raw materials

-15.24

-9.99

-13.9

-10.52

As % of sales

37.99

39.68

37.03

36.25

Employee costs

-15.82

-12.96

-15.12

-11.92

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

0.74

-2.53

0.43

0.32

Depreciation

-0.27

-0.17

-0.24

-0.18

Tax paid

0.12

0.01

-0.15

-0.05

Working capital

2

-0.44

2.46

-5.43

Other operating items

View Cash Flow
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

59.4

-32.93

29.39

14.73

Op profit growth

-140.37

-505.13

111.34

304.73

EBIT growth

-153.58

-394.3

31.98

65.61

Net profit growth

-134.61

-1,012.54

1.98

-1,928.47

View Ratios
Particulars (Rupees in Crores.)Mar-2021Mar-2020Mar-2019

Gross Sales

25.18

37.54

31.03

Excise Duty

0

0

0

Net Sales

25.18

37.54

31.03

Other Operating Income

0

0

0

Other Income

0.8

0.29

0.32

Gujarat Terce Laboratories Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,798.6

156.544,31,544.39863.290.755,123.6798.33

Divis Laboratories Ltd

DIVISLAB

6,210.35

89.741,64,865.285180.482,302513.62

Cipla Ltd

CIPLA

1,534.4

29.271,23,920.061,178.160.853,969.86360.73

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,361.6

69.541,13,766.714600.832,376222.38

Mankind Pharma Ltd

MANKIND

2,558.95

51.151,02,527.44634.4302,529.74269.23

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Gujarat Terce Laboratories Ltd

Management

Register Office

Registrar Office

Whole-time Director

Amrutbhai P Prajapati

Independent Director

Chhayaben Ashwinbhai Shah

Independent Director

Viplav Suryakantbhai Khamar

Managing Director & CEO

Aalap Prajapati

Independent Director

Surendra Kumar Sharma

Independent Director

Navinchandra Patel

Chairman & Wholetime Director

Natwarbhai P Prajapati

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Gujarat Terce Laboratories Limited, incorporated in 1985, produces branded generic formulations for the domestic market. Over its more than three-decade business journey, the Company developed an extensive product basket comprising 50 brands covering multiple therapeutic areas which are marketed by its 180+ strong MR team across 13 Indian states. Headquartered in Ahmedabad, the Company has its fully automated facility at Chhatral, in Gandhinagar, Gujarat By 1986, Terce had established its presence in Gujarat and Rajasthan with a firm footing. In 1992, the management raised public equity to give concrete shape and listed the Company on Bombay Stock Exchange. In same year, Company established extensive manufacturing facility at Chhatral in Gandhinagar, Gujarat. As India heralded new leaps in the pharma sector to become a global force to reckon with by 2005, the Company closely followed the narrative with ferocious growth expanding presence in the domestic and international market.The Company is an ISO 9001 certified, WHO-GMP compliant operating facility manufactures world-class formulations and healthcare products that feature in acute and chronic therapeutic areas. It engaged into manufacture and sale of pharmaceutical formulations and ayurvedic medicines in India and internationally. It offers products in the form of tablets, capsules, syrups, and injections. The installed capacity of the Company is 270 million tablets and 108 million capsules per annum.The facility is ISO 90
Read More

Company FAQs

What is the Gujarat Terce Laboratories Ltd share price today?

The Gujarat Terce Laboratories Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹77.38 today.

What is the Market Cap of Gujarat Terce Laboratories Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Gujarat Terce Laboratories Ltd is ₹57.42 Cr. as of 04 Dec ‘24

What is the PE and PB ratio of Gujarat Terce Laboratories Ltd?

The PE and PB ratios of Gujarat Terce Laboratories Ltd is 21.52 and 6.36 as of 04 Dec ‘24

What is the 52 Week High and Low of Gujarat Terce Laboratories Ltd?

The 52-week high/low is the highest and lowest price at which a Gujarat Terce Laboratories Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Gujarat Terce Laboratories Ltd is ₹25.84 and ₹94.9 as of 04 Dec ‘24

What is the CAGR of Gujarat Terce Laboratories Ltd?

Gujarat Terce Laboratories Ltd's CAGR for 5 Years at 53.54%, 3 Years at 75.38%, 1 Year at 165.56%, 6 Month at 36.90%, 3 Month at 29.45% and 1 Month at -14.86%.

What is the shareholding pattern of Gujarat Terce Laboratories Ltd?

The shareholding pattern of Gujarat Terce Laboratories Ltd is as follows:
Promoters - 37.03 %
Institutions - 0.00 %
Public - 62.97 %

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2024, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp